8 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18556178 | GPR35 Agonist Compounds | HSU, GRACE CHING | 1627 | Non-Final OA | Oct 19, 2023 |
| 18280611 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR DEMENTIA | MOTEVALLI, OROD | 1628 | Non-Final OA | Sep 06, 2023 |
| 18258065 | SARS-COV-2 MPRO INHIBITOR COMPOUNDS | HAVLIN, ROBERT H | 1626 | Non-Final OA | Jun 16, 2023 |
| 18304801 | MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM | LI, RUIXIANG | 1674 | Final Rejection | Apr 21, 2023 |
| 18031416 | LINEAR APELIN RECEPTOR AGONISTS | COFFA, SERGIO | 1658 | Non-Final OA | Apr 12, 2023 |
| 17920583 | H4 ANTAGONIST COMPOUNDS | MCDOWELL, BRIAN E | 1624 | Final Rejection | Oct 21, 2022 |
| 17909907 | GLP RECEPTOR AGONISTS | BOWLES, DAVID PAUL | 1654 | Non-Final OA | Sep 07, 2022 |
| 17107617 | METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS | PAK, MICHAEL D | 1674 | Final Rejection | Nov 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial